|
|
|
|
||
Re: ABIO $2.21Looks like the ground floor of a good thing. Any long term lurkers here? Did this company attempt a trail some time ago, and fail, because they were not aware of the genetic predisposition of the population? Now with the diagnostic kit, ABIO can target the appropriate community of individuals....Seems like a guaranteed winner... Market capitalization is sooooo small. Any home run in this billion dollar market will be richly rewarded... All comments welcome, even from shorts! {smile} Bagbest. |
return to message board, top of board |